Welcome to Letter II of The CHARGE Brief. This issue includes a conversation with Andrew Burkowski on the future of AI governance; scrutiny of UpDoc's 'historic' FDA clearance; reflections on the OpenEvidence - EchoNext partnership; analysis of the Mayo Clinic lawsuit and the Xsolis breach affecting 1.3 million patients; and the most recent job roundup.
In this issue
Interviews
Insights
- Strategic Ambiguity: UpDoc Characterizes Its FDA Clearance as 'Historic;' CHARGE Isn't Sure
- The Integration Trap: OpenEvidence's Integrated EchoNext Before it Demonstrated Clinical Utility
